![Ronald Newbold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Newbold
Direktor/Vorstandsmitglied bei
The University of Virginia Patent Foundation
Profil
Ronald C.
Newbold is currently the Vice Chairman at The University of Virginia Patent Foundation.
Previously, he held senior positions at Merck & Co., Inc., Sentigen Holding Corp., AVANT Immunotherapeutics, Inc., Celldex Therapeutics, Inc. (Old), Auspex Pharmaceuticals, Inc., and Sentigen Biosciences, Inc. He also served as the Vice President of Business Development at Celldex Therapeutics, Inc. Dr. Newbold holds a doctorate from the University of Rochester and an MBA from The Trustees of Columbia University in The City of New York.
Aktive Positionen von Ronald Newbold
| Unternehmen | Position | Beginn |
|---|---|---|
The University of Virginia Patent Foundation
 The University of Virginia Patent Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a civic and social association | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ronald Newbold
| Unternehmen | Position | Ende |
|---|---|---|
Sentigen Holding Corp.
 Sentigen Holding Corp. BiotechnologyHealth Technology Provides research and development services for drug discovery | Geschäftsführer | 27.04.2011 |
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | 30.01.2009 |
AVANT Immunotherapeutics, Inc.
 AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Corporate Officer/Principal | 01.10.2008 |
Sentigen Biosciences, Inc. | Corporate Officer/Principal | 01.01.2004 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.01.2000 |
Ausbildung von Ronald Newbold
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sentigen Holding Corp.
Sentigen Holding Corp. BiotechnologyHealth Technology Provides research and development services for drug discovery | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Celldex Therapeutics, Inc. (Old)
 Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Sentigen Biosciences, Inc. | |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
The University of Virginia Patent Foundation
The University of Virginia Patent Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a civic and social association | Commercial Services |
